JAKARTA - Indonesia Ministry of Health (Kemenkes) has published a letter (SE) addressed to all the Heads of provincial and district/city Health Offices regarding the implementation of the Covid-19 vaccination.

The letter stated, one of which is the implementation of vaccination for comorbid groups with conditions that must be fulfilled.

The letter with number HK.02.02/I/368/2021 about The Implementation of Covid-19 Vaccination for the Target Group of Elderly, Comorbids and Covid-19 Survivors, was signed on Thursday (11/02/2021) by the Plt. of Director General of Disease Prevention and Control Ministry of Health, Maxi Rein Rondonuwu.

"The National Immunization Expert Advisory Committee has submitted a study that Covid-19 vaccination can be given to the age group of 60 years and over, comorbids, Covid-19 survivors, and breastfeeding mothers with additional anamnesis first," said Maxi.

The implementation of vaccination must still follow the technical guidelines for the implementation of Covid-19 vaccination, including for the elderly group, 2 doses of vaccination for the 60 years and over age group with an interval of 28 days.

Meanwhile, the comorbid group, in this case people who have hypertension, can be vaccinated unless the blood pressure is above 180/110 MmHg, and blood pressure measurements should be done before the screening table. For the comorbid group with diabetes can be vaccinated as long as there are no acute complications.

The comorbid cancer survivors can still be given vaccines. Other than that, the Covid-19 survivors also can be vaccinated if they have been recovered more than 3 months. The breastfeeding mothers can also be vaccinated.

All Vaccination Service Posts must be equipped with anaphylaxis kits and are under the responsibility of the Health Center or Hospital.

In this regard, it is hoped that the Heads of provincial and district/city Health Offices throughout Indonesia can immediately take the necessary corrective actions in order to improve the implementation of vaccinations and accelerate the increase in Covid-19 vaccination coverage.**/ril